News - Neurological, Cardio-vascular


Popular Filters

1 to 25 of 30 results

Pharmacovigilance Risk Assessment Committee April meeting highlights

Pharmacovigilance Risk Assessment Committee April meeting highlights


The European Medicines Agency’s Pharmacovigilance Risk Assessment Committee (PRAC) gave a recommendation…

Cardio-vascularEuropeMen's HealthNeurologicalPharmaceuticalRegulationRespiratory and Pulmonary

MedImmune joins research collaboration with the University of California

MedImmune joins research collaboration with the University of California


MedImmune, the global biologics research and development arm of Anglo-Swedish drug major AstraZeneca,…

Antibiotics and Infectious diseasesCardio-vascularInflammatory diseasesMedImmuneMetabolicsNeurologicalOncologyPharmaceuticalResearchRespiratory and PulmonaryUSA

Radiopharmaceuticals market to hit a value of $7.9 billion by 2018


The radiopharmaceuticals market has been forecast to exceed a value of $7.9 billion by 2018, driven by…

Cardio-vascularGlobalMarkets & MarketingNeurologicalOncologyPharmaceutical

Generic versions of Trilipix debut in USA; Mylan sued by UCB


Impax Laboratories (Nasdaq: IPXL) today announced yesterday (July 15) that it is commencing shipment…

AbbVieCardio-vascularGenericsImpax LaboratoriesLegalMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaPatentsTripilixUCBVimpat

Abcam in deal with Pfizer to supply compounds to researchers


UK-based Abcam (AIM: ABC), a producer and distributor of protein research tools, has entered into a license…


Impax launches authorized generic of Zomig, as Mylan debuts copy of Tricor in USA


US drugmaker Impax Laboratories (Nasdaq: IPXL) says that its generics division, Global Pharmaceuticals,…

AbbVieAstraZenecaCardio-vascularGenericsImpax LaboratoriesMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaTricorZomig

EMA Pharmacovigilance committee calls for Tredaptive suspension; contraceptives update


At meetings held last week, the European Medicines Agency's Pharmacovigilance Risk Assessment Committee…

Cardio-vascularEuropeMerck & CoNeurologicalPharmaceuticalRegulationReproductivetetrazepamTredaptive

Japanese approvals for Novo's Ryzodeg, UCB/Otsuka's Neupro and B-MS/Pfizer's Eliquis


Danish insulin giant Novo Nordisk (NOVN: NV) revealed on December 15 that the Japanese Ministry of Health,…

Asia-PacificBristol-Myers SquibbCardio-vascularDiabetesEliquisNeuproNeurologicalNovo NordiskOtsukaPfizerPharmaceuticalRegulationRyzodegUCB

NeuroVive and Sihuan Pharma to develop and commercialize CicloMulsion and NeuroSTAT in China


Swedish mitochondrial medicine firm NeuroVive has announced a collaboration with China's Sihuan Pharmaceutical…

Asia-PacificCardio-vascularCicloMulsionLicensingNeurologicalNeuroSTATNeuroVivePharmaceuticalSihuan Pharmaceutical

Germany invalidates Seroquel patent; Merck drops combo diabetes drug development


Anglo-Swedish drug major AstraZeneca (LSE: AZN) said last evening that the Federal Patent Court in Germany…

AstraZenecaatorvastatinCardio-vascularDiabetesJanuviaMerck & CoMK-0431ENeurologicalPatentsPharmaceuticalResearchSeroquel XR

Mylan debuts first generic Diovan HCT and Antivert copy in USA


US generic drugmaker Mylan (Nasdaq: MYL) last Friday received final approval from the US Food and Drug…

AntivertCardio-vascularDiovan HCTGenericsMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaNovartisPfizerRegulation

Wockhardt generic versions of Pfizer's Geodon and AstraZeneca's Plendil OKed by FDA


Wockhardt generic versions of Pfizer's Geodon and AstraZeneca's Plendil OKed by FDA

AstraZenecaCardio-vascularGenericsGeodonMarkets & MarketingNeurologicalNorth AmericaPfizerPlendilRegulationWockhardt

EMA calls for curbs on trimetazidine-containing and tolperisone medicines


The European Medicines Agency on Friday recommended restricting the use of trimetazidine-containing medicines…


Novartis makes Tekturna label change, updates on Gilenya and stops alisporivir trial


In a day of mixed news for the Swiss drug major, Novartis (NOVN: VX) said yesterday that it has updated…


Mylan debuts Lescol copy; Impax challenges Gralise patent


US generic drug major Mylan (Nasdaq: MYL) revealed last Friday that it has begun shipping its generic…

Cardio-vascularDepomedGenericsGraliseImpax LaboratoriesLescolMarkets & MarketingMylan LaboratoriesNeurologicalNorth AmericaNovartisPatentsRegulation

RegeneRx explores strategic options


US biotech firm RegeneRx Biopharmaceuticals. (OTC Bulletin Board: RGRX) revealed yesterday that it has…


Watson settles over Exalgo; gets favorable news on enoxaparin


US generic drugmaker Watson Pharmaceuticals (NYSE: WPI) says that its subsidiary, Watson Laboratories,…

Cardio-vascularEnoxaparin Sodium InjectionExalgoGenericsLegalLovenoxMallinckrodtMomenta PharmaceuticalsNeurologicalNorth AmericaSanofiWatson Pharmaceuticals

Sobi buys rights to novel neonatology treatment


Stockholm-based Swedish Orphan Biovitrum (STO: SOBI) has signed a global licensing agreement with the…

BumetanideCardio-vascularLicensingNeurologicalOnly for Children PharmaceuticalsPharmaceuticalSwedish Orphan Biovitrum

FDA strengthens warnings on Sanofi’s Multaq; Aubagio disappoints


The US Food and Drug Administration (FDA) has completed a safety review of French drug major Sanofi’s…


1 to 25 of 30 results

Back to top